Literature DB >> 15197008

Combined modality therapy of esophageal cancer: changes in the standard of care?

Manish A Shah, David P Kelsen.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15197008     DOI： 10.1245/ASO.2004.04.907

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  8 in total

Review 1.  Neoadjuvant treatment of esophageal cancer.

Authors:  Nicholas P Campbell; Victoria M Villaflor
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

Review 2.  Multidisciplinary approach for patients with esophageal cancer.

Authors:  Victoria M Villaflor; Marco E Allaix; Bruce Minsky; Fernando A Herbella; Marco G Patti
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

3.  Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.

Authors:  Gang Lin; Xiao-Jiang Sun; Qian-Bo Han; Zhun Wang; Ya-Ping Xu; Jia-Lei Gu; Wei Wu; G U Zhang; Jin-Lin Hu; Wen-Yong Sun; Wei-Min Mao
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

4.  Esophageal adenocarcinoma arising from Barrett's dysplasia: a case report of double occurrence and prolonged survival after chemotherapy.

Authors:  Hemender S Vats; Tarit K Banerjee; Jeffrey Resnick; Qaseem Khan
Journal:  Clin Med Res       Date:  2006-09

5.  Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study.

Authors:  Sarah J Crane; G Richard Locke; William S Harmsen; Alan R Zinsmeister; Yvonne Romero; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

6.  Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer.

Authors:  A Gines; S D Cassivi; J A Martenson; C Schleck; C Deschamps; F A Sinicrope; S R Alberts; J A Murray; Alan R Zinsmeister; Enrique Vazquez-Sequeiros; F C Nichols; R C Miller; J F Quevedo; M S Allen; J A Alexander; T Zais; M G Haddock; Y Romero
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

7.  Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo.

Authors:  Lei Wang; Jianfang Feng; Xiaonan Chen; Wei Guo; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Shijie Zhang; Guoqiang Zhao
Journal:  Cancer Cell Int       Date:  2014-07-18       Impact factor: 5.722

8.  An EGFR/HER2-Bispecific and enediyne-energized fusion protein shows high efficacy against esophageal cancer.

Authors:  Xiao-Fang Guo; Xiao-Fei Zhu; Wan-Cai Yang; Sheng-Hua Zhang; Yong-Su Zhen
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.